A policy approach to the development of molecular diagnostic tests

@article{Schulman2010APA,
  title={A policy approach to the development of molecular diagnostic tests},
  author={Kevin A. Schulman and Sean R. Tunis},
  journal={Nature Biotechnology},
  year={2010},
  volume={28},
  pages={1157-1159}
}
Efficiently generating evidence of clinical utility is a major challenge for ensuring clinical adoption of valuable diagnostics. A new approach to reimbursement in the United States offers a balance between evidence and incentives for molecular diagnostic tests.